# AHR-CYP1A1 Axis Perturbation and Necroptosis in 1,2-Dichloroethane Hepatotoxicity: Elucidation by an Integrated Network Toxicology and In Vitro Validation

**Authors:** Yichang Liu, Huijie Luo, Zhiling Tian, Hewen Dong, Dong Ma, Xiaojing Meng, Ningguo Liu

PMC · DOI: 10.3390/toxics14020136 · Toxics · 2026-01-30

## TL;DR

This study explores how 1,2-dichloroethane causes liver damage by activating a specific pathway and triggering cell death.

## Contribution

The study reveals a dual-phase mechanism of 1,2-DCE-induced hepatotoxicity involving the AHR-CYP1A1 axis and necroptosis.

## Key findings

- 1,2-DCE triggers rapid AHR nuclear translocation and transient CYP1A1 upregulation.
- Prolonged exposure leads to CYP1A1 suppression and activation of necroptosis markers.
- AHR is identified as a potential target for mitigating 1,2-DCE-induced liver injury.

## Abstract

As a typical halogenated hydrocarbon environmental pollutant, 1,2-dichloroethane (1,2-DCE) exhibits clinically confirmed hepatotoxicity with incompletely understood mechanisms. This study integrated network toxicology, molecular docking, and in vitro experiments to investigate necroptosis in 1,2-DCE-induced liver injury. Computational analysis predicted involvement of the aryl hydrocarbon receptor (AHR)/cytochrome P450 1A1 (CYP1A1) pathway, and molecular docking suggested potential binding between 1,2-DCE and AHR (−6.5 kcal/mol). CCK-8 assays showed that 1,2-DCE reduced THLE-2 hepatocyte viability in a concentration-dependent manner. Notably, 1,2-DCE triggered rapid AHR nuclear translocation within 1 h and transiently upregulated CYP1A1 at both the transcriptional and protein levels (3–6 h). Further studies revealed elevated intracellular reactive oxygen species (ROS) at 24 h. After 48 h exposure, CYP1A1 expression was significantly suppressed, accompanied by activation of necroptosis markers, including increased lactate dehydrogenase (LDH) release, enhanced propidium iodide (PI) staining, and elevated phosphorylation of receptor-interacting protein kinase 3 (RIPK3) and mixed lineage kinase domain-like protein (MLKL). These findings reveal a dual-phase mechanism: an early adaptive stress response via the AHR-CYP1A1 axis, followed by pathway dysfunction and transition to necroptosis, suggesting AHR as a potential target for intervening in 1,2-DCE-induced hepatotoxicity.

## Linked entities

- **Genes:** AHR (aryl hydrocarbon receptor) [NCBI Gene 196], CYP1A1 (cytochrome P450 family 1 subfamily A member 1) [NCBI Gene 1543], RIPK3 (receptor interacting serine/threonine kinase 3) [NCBI Gene 11035], MLKL (mixed lineage kinase domain like pseudokinase) [NCBI Gene 197259]
- **Proteins:** CYP1A1 (cytochrome P450 family 1 subfamily A member 1), RIPK3 (receptor interacting serine/threonine kinase 3), MLKL (mixed lineage kinase domain like pseudokinase)
- **Chemicals:** 1,2-dichloroethane (PubChem CID 11), doxorubicin (PubChem CID 31703)

## Full-text entities

- **Genes:** RELA (RELA proto-oncogene, NF-kB subunit) [NCBI Gene 5970] {aka AIF3BL3, CMCU, NFKB3, p65}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, MAPK14 (mitogen-activated protein kinase 14) [NCBI Gene 1432] {aka CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2}, TBP (TATA-box binding protein) [NCBI Gene 6908] {aka GTF2D, GTF2D1, HDL4, SCA17, TBP1, TFIID}, ARNT (aryl hydrocarbon receptor nuclear translocator) [NCBI Gene 405] {aka ARNT1, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA}, RIPK1 (receptor interacting serine/threonine kinase 1) [NCBI Gene 8737] {aka AIEFL, IMD57, RIP, RIP-1, RIP1}, cyp1a (cytochrome P450, family 1, subfamily A) [NCBI Gene 140634] {aka cyp1a1, wu:fb63b04, zfCYP1A, zgc:109747}, CYP2E1 (cytochrome P450 family 2 subfamily E member 1) [NCBI Gene 1571] {aka CPE1, CYP2E, P450-J, P450C2E}, BLNK (B cell linker) [NCBI Gene 29760] {aka AGM4, BASH, BLNK-S, LY57, SLP-65, SLP65}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, CYP27B1 (cytochrome P450 family 27 subfamily B member 1) [NCBI Gene 1594] {aka CP2B, CYP1, CYP1alpha, CYP27B, P450c1, PDDR}, RIPK3 (receptor interacting serine/threonine kinase 3) [NCBI Gene 11035] {aka RIP3}, MLKL (mixed lineage kinase domain like pseudokinase) [NCBI Gene 197259] {aka hMLKL}, rela (RELA proto-oncogene, NF-kB subunit a) [NCBI Gene 415099] {aka nfkb3, p65}, AHR (aryl hydrocarbon receptor) [NCBI Gene 196] {aka FVH3, RP85, bHLHe76}, TUBB (tubulin beta class I) [NCBI Gene 203068] {aka CDCBM6, CSCSC1, M40, OK/SW-cl.56, TUBB1, TUBB5}, CYP1A1 (cytochrome P450 family 1 subfamily A member 1) [NCBI Gene 1543] {aka AHH, CP11, CYP1, CYPIA1, P1-450, P450-C}
- **Diseases:** hepatic (MESH:D056486), Liver injury (MESH:D017093), alcohol-associated liver disease (MESH:D008108), Necrotic Cell (MESH:D002292), hepatocellular carcinoma (MESH:D006528), necrosis (MESH:D009336), Cytotoxicity (MESH:D064420), jaundice (MESH:D007565), MASH (MESH:D005234), autoimmune diseases (MESH:D001327), vacuolar degeneration (MESH:C536522), hypoxia (MESH:D000860), psoriasis (MESH:D011565), hepatic disruption (MESH:D015451), liver diseases (MESH:D008107), inflammation (MESH:D007249), injury to (MESH:D014947), male reproductive impairment (MESH:D005832), liver fibrosis (MESH:D008103), atrophy (MESH:D001284), lung injury (MESH:D055370), cancers (MESH:D009369), poisoning (MESH:D011041)
- **Chemicals:** paraformaldehyde (MESH:C003043), glutathione (MESH:D005978), CO2 (MESH:D002245), DMSO (MESH:D004121), DAPI (MESH:C007293), sulfur dioxide (MESH:D013458), ROS (MESH:D017382), 1,2-DCE (MESH:C024565), PBS (MESH:D007854), hydrogen (MESH:D006859), PVDF (MESH:C024865), cypermethrin (MESH:C017160), penicillin (MESH:D010406), DMEM (-), PI (MESH:D011419), dioxin (MESH:D004147), 2,3,7,8-tetrachlorodibenzo-p-dioxin (MESH:D000072317), Tapinarof (MESH:C571829), PHE (MESH:D010649), ARG (MESH:D001120), fluorescein (MESH:D019793), Toluene (MESH:D014050), halogenated hydrocarbon (MESH:D006846), DCFH-DA (MESH:C029569), water (MESH:D014867), CCK-8 (MESH:D012844), VAL (MESH:D014633), ethanol (MESH:D000431), 2-CA (MESH:C006972), GLU (MESH:D018698), SDS (MESH:D012967), WST-8 (MESH:C476329), Triton X-100 (MESH:D017830), aromatic hydrocarbons (MESH:D006841), streptomycin (MESH:D013307), Chloroacetaldehyde (MESH:C004656)
- **Species:** Danio rerio (leopard danio, species) [taxon 7955], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** C0019M, C1352S
- **Cell lines:** CCK-8 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_2873), THLE-2 — Homo sapiens (Human), Transformed cell line (CVCL_3803), CL-0833 — Homo sapiens (Human), Transformed cell line (CVCL_K593)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12945068/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12945068/full.md

## References

44 references — full list in the complete paper: https://tomesphere.com/paper/PMC12945068/full.md

---
Source: https://tomesphere.com/paper/PMC12945068